{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-035098","form_type":"8-K","ticker":"ELAB","cik":"0001840563","company_name":"PMGC Holdings Inc.","filed_at":"2026-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.489273+00:00","generated_at":"2026-05-15T08:41:13.141898+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"PMGC subsidiary Northstrive and MOA amend license milestones for BLS-M22, add amendment fee","bullets":["Third Amendment updates development milestones for human health field, including pre-clinical, IND, Phase 1-3, FDA marketing approval.","For BLS-M22, Phase 1 trial may be excused; milestone payment deferred to Phase 2 start.","PMGC to pay MOA a one-time amendment fee within 30 days of effective date (amount redacted).","Amendment effective as of March 24, 2026; signed by CEO Graydon Bensler and MOA COO Tiger Yoon."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-035098","json":"https://secwatch.observer/filing/0001213900-26-035098.json","markdown":"https://secwatch.observer/filing/0001213900-26-035098.md","text":"https://secwatch.observer/filing/0001213900-26-035098.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840563/000121390026035098/0001213900-26-035098-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840563/000121390026035098/ea0283722-8k_pmgc.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:41:13.141898+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d930d5a8969e45d8070b894b92fa9e87d2cd62a5","claim":"PMGC Holdings Inc. amended Third Amendment with MOA Life Plus Co., Ltd. (effective 2026-03-24).","evidence_excerpt":"Northstrive Biosciences Inc. (“Northstrive”), a wholly owned subsidiary of PMGC Holdings Inc. (the “Company”), entered into a Third Amendment to License Agreement (the “Third Amendment”) with MOA Life Plus Co., Ltd. (“MOA”), a corporation organized under the laws of the Republic of Korea.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840563/000121390026035098/0001213900-26-035098-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"license"},{"label":"Counterparty","value":"MOA Life Plus Co., Ltd."},{"label":"Effective","value":"2026-03-24"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}